| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447416 | European Journal of Cancer | 2011 | 8 Pages |
Abstract
Patients considering Phase 1 trials may be a self-selected group with optimistic expectations of personal benefit driving trial entry rather than altruism. Achieving genuinely informed consent and avoidance of therapeutic misconceptions in such patients may be difficult.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
S. Catt, C. Langridge, L. Fallowfield, D.C. Talbot, V. Jenkins,